Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada
Mayer S, Fairbairn N, Fowler A, Boyd J, Kerr T, McNeil R. Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada. Harm Reduction Journal 2025, 22: 116. PMID: 40615907, PMCID: PMC12228173, DOI: 10.1186/s12954-025-01262-4.Peer-Reviewed Original ResearchConceptsSocial servicesStructural vulnerabilityVancouver’s Downtown Eastside neighbourhoodRelated careInjectable opioid agonist treatmentUse-related risksHousing instabilityVulnerability lensObservational fieldworkVulnerability contextFieldwork observationsOpioid agonist treatment engagementQualitative interviewsPeople's engagementQualitative studies of patients' experiencesExperiences of barriersStudies of patients' experiencesHealthcare provider supervisionMobility challengesFollow-up interviewsImprove accessSocial supportQualitative studyFieldworkBarriers to treatment
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply